Biotechnology Europe Approves Bristol Myers Squibb’s CAR-T Therapy For Early Treatment Of Type Of Blood Cancer – Bristol-Myers Squibb (NYSE:BMY) Read more
Biotechnology Gilead’s Aggressive Push Beyond HIV Treatments – Plans To Increase Cancer-Focused CAR-T Treatment Production – Gilead Sciences (NASDAQ:GILD) Read more